Birdwatch Note
2023-11-30 12:11:26 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
China did not allow Pfizer/Moderns mRNA products to be used in their country. It wasn't until this year that they rolled out their own mRNA drugs. https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-its-first-mrna-vaccine-domestic-drugmaker-cspc-2023-03-22/
Written by 12594630A9C7F0830FF7668695AA6028F72BFD2D0DBF9546C3055819B5A0F162
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1730148701048610929
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1730197846169653548
- noteId - 1730197846169653548
- participantId -
- noteAuthorParticipantId - 12594630A9C7F0830FF7668695AA6028F72BFD2D0DBF9546C3055819B5A0F162 Participant Details
- createdAtMillis - 1701346286706
- tweetId - 1730148701048610929
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- China did not allow Pfizer/Moderns mRNA products to be used in their country. It wasn't until this year that they rolled out their own mRNA drugs. https://www.reuters.com/business/healthcare-pharmaceuticals/china-approves-its-first-mrna-vaccine-domestic-drugmaker-cspc-2023-03-22/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-11-30 12:11:26 UTC (1701346286706) |
2023-11-30 17:41:41 UTC (1701366101150) |
CURRENTLY_RATED_HELPFUL | 2023-12-01 03:12:04 UTC (1701400324779) |
CURRENTLY_RATED_HELPFUL | 2023-11-30 17:41:41 UTC (1701366101150) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-11-30 17:14:04 -0600 | Rating Details | |
2023-11-30 16:42:07 -0600 | Rating Details | |
2023-11-30 15:40:19 -0600 | Rating Details | |
2023-11-30 14:18:23 -0600 | Rating Details | |
2023-11-30 13:32:26 -0600 | Rating Details | |
2023-11-30 12:07:12 -0600 | Rating Details | |
2023-11-30 10:12:23 -0600 | Rating Details | |
2023-11-30 09:44:20 -0600 | Rating Details | |
2023-11-30 08:58:16 -0600 | Rating Details | |
2023-11-30 08:34:17 -0600 | Rating Details | |
2023-11-30 08:30:01 -0600 | Rating Details | |
2023-11-30 08:14:10 -0600 | Rating Details | |
2023-11-30 08:06:00 -0600 | Rating Details | |
2023-11-30 07:33:36 -0600 | Rating Details | |
2023-11-30 07:31:28 -0600 | Rating Details | |
2023-11-30 06:59:14 -0600 | Rating Details | |
2023-11-30 06:55:45 -0600 | Rating Details | |
2023-11-30 06:55:30 -0600 | Rating Details | |
2023-11-30 06:47:45 -0600 | Rating Details | |
2023-11-30 06:47:32 -0600 | Rating Details | |
2023-11-30 06:43:57 -0600 | Rating Details | |
2023-11-30 06:39:18 -0600 | Rating Details | |
2023-11-30 06:32:35 -0600 | Rating Details | |
2023-11-30 06:24:32 -0600 | Rating Details | |
2023-11-30 06:21:14 -0600 | Rating Details | |
2023-11-30 22:33:21 -0600 | Rating Details | |
2023-11-30 19:05:29 -0600 | Rating Details | |
2023-11-30 16:45:13 -0600 | Rating Details | |
2023-11-30 16:26:01 -0600 | Rating Details | |
2023-11-30 15:23:32 -0600 | Rating Details | |
2023-11-30 11:59:02 -0600 | Rating Details | |
2023-11-30 11:39:35 -0600 | Rating Details | |
2023-11-30 08:23:43 -0600 | Rating Details | |
2023-11-30 08:17:14 -0600 | Rating Details | |
2023-11-30 07:49:48 -0600 | Rating Details | |
2023-11-30 07:44:54 -0600 | Rating Details | |
2023-11-30 07:21:12 -0600 | Rating Details | |
2023-11-30 07:08:57 -0600 | Rating Details | |
2023-11-30 07:05:42 -0600 | Rating Details | |
2023-11-30 06:30:02 -0600 | Rating Details | |
2023-11-30 06:28:06 -0600 | Rating Details | |
2023-11-30 06:27:10 -0600 | Rating Details | |
2023-11-30 06:25:40 -0600 | Rating Details | |
2023-11-30 06:25:03 -0600 | Rating Details | |
2023-11-30 06:17:46 -0600 | Rating Details | |
2023-12-02 11:11:33 -0600 | Rating Details | |
2023-12-02 10:06:02 -0600 | Rating Details | |
2023-12-01 18:44:47 -0600 | Rating Details | |
2023-12-01 15:22:07 -0600 | Rating Details | |
2023-12-01 14:48:39 -0600 | Rating Details | |
2023-12-01 06:19:01 -0600 | Rating Details | |
2023-12-01 05:50:39 -0600 | Rating Details | |
2023-12-01 01:48:28 -0600 | Rating Details | |
2023-12-01 00:56:14 -0600 | Rating Details | |
2023-12-04 11:39:20 -0600 | Rating Details | |
2023-12-01 06:52:17 -0600 | Rating Details | |
2023-11-30 16:52:53 -0600 | Rating Details | |
2023-11-30 16:51:03 -0600 | Rating Details | |
2023-11-30 16:03:43 -0600 | Rating Details | |
2023-11-30 14:51:27 -0600 | Rating Details | |
2023-11-30 08:46:39 -0600 | Rating Details | |
2023-11-30 08:16:39 -0600 | Rating Details | |
2023-11-30 06:49:50 -0600 | Rating Details | |
2023-11-30 06:26:12 -0600 | Rating Details | |
2023-11-30 06:16:17 -0600 | Rating Details |